author-photo

Richard M. Lee-Ying

Tom Baker Cancer Centre

60

Papers

85

Citations

Citation Trend

Filter By

Papers (45) Sort By

Journal Conference Others

Association between oncology drug review times and public funding recommendations.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Determining the cancer diagnostic interval using administrative data in a cohort of patients with pancreatic cancer.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
604P Predictive genomic biomarkers in non-metastatic castration resistant prostate cancer (nmCRPC) treated with androgen receptor pathway inhibitors (ARPi)

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Sequence decision making for cabazitaxel (Cbz) versus abiraterone (Abt) or enzalutamide (Enz) post-docetaxel (Dtx) in a publicly funded health care system.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Real-World Outcomes of Oxaliplatin-Based Chemotherapy on R0 Resected Colonic Liver Metastasis: Chemotherapy for Resected CLM

2021 Clinical Colorectal Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy.

2021
Show All
- Source
- Cite
- Save
Citations (2)
Clinical outcomes of patients with metastatic castration-resistant prostate cancer (mCRPC) receiving radium-223 (Ra-223) early versus late in the treatment sequence.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Impact of lenvatinib (LEN) dose-intensity and starting dose on survival among patients with advanced hepatocellular carcinoma (HCC): Results from a Canadian multicenter database (HCC CHORD).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Determining the cancer diagnostic interval using administrative data in a cohort of patients with pancreatic ductal adenocarcinoma (PDAC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Clinical outcomes of abiraterone acetate + prednisone (AA) + bone resorption inhibitors (BRI) versus AA alone as first-line therapy for castration-resistant prostate cancer (CRPC) with bone metastases (BM) in an international multicenter database.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)